You are here: Welcome to the MPKB » Welcome to the MPKB » Health, food and drink » Aiming at Health » Health Maintenance and Olmesartan
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:food:aim_health:aging [02.24.2019] – [General research on aging] sallieqhome:food:aim_health:aging [02.24.2019] – [Recent studies showed] sallieq
Line 43: Line 43:
   * inhibit liver fibrosis and aid liver healing(({{pubmed>long:12871826}}))   * inhibit liver fibrosis and aid liver healing(({{pubmed>long:12871826}}))
   * reduce insulin resistance in rats(({{pubmed>long:15127887}}))   * reduce insulin resistance in rats(({{pubmed>long:15127887}}))
-  * 6 mg/kg olmesartan reduces the inflammatory process and bone loss in rats(({{pubmed>long:23775504}}))+  * **6 mg/kg** olmesartan reduces the inflammatory process and bone loss in rats(({{pubmed>long:23775504}}))
   * protect the mitochondria from age-associated damage from oxidation(({{pubmed>long:12709417}}))   * protect the mitochondria from age-associated damage from oxidation(({{pubmed>long:12709417}}))
   * play a protective role against proliferative diabetic retinopathy (({{pubmed>long:17560613}}))   * play a protective role against proliferative diabetic retinopathy (({{pubmed>long:17560613}}))
Line 94: Line 94:
 === A number of studies have found === === A number of studies have found ===
  
-that olmesartan and other ARBs possess various ways of protecting the kidneys from the effects of inflammation and cytokine damage: +that olmesartan possesses various ways of protecting the kidneys from the effects of inflammation and cytokine damage: 
  
   * in circadian rhythms between HR and MAP in CKD: Synchronization between the two rhythms was progressively lost as renal function deteriorated, and Olmesartan partly restored the synchronization (({{pubmed>long:23511341}}))    * in circadian rhythms between HR and MAP in CKD: Synchronization between the two rhythms was progressively lost as renal function deteriorated, and Olmesartan partly restored the synchronization (({{pubmed>long:23511341}})) 
   * in hypertensive patients with CKD, olmesartan add-on therapy improves the ambulatory BP profile via a preferential reduction in nighttime BP with concomitant renal injury inhibition (({{pubmed>long:23154587}}))    * in hypertensive patients with CKD, olmesartan add-on therapy improves the ambulatory BP profile via a preferential reduction in nighttime BP with concomitant renal injury inhibition (({{pubmed>long:23154587}})) 
-  * results suggest olmesartan can help decrease plasma AGE levels in patients on HD (({{pubmed>long:22149003}})) +  * results suggest olmesartan can help decrease plasma AGE levels in patients on Hemodialysis (({{pubmed>long:22149003}})) 
   * renal protective effects of olmesartan may be better than those of other ARBs (({{pubmed>long:3862195}}))    * renal protective effects of olmesartan may be better than those of other ARBs (({{pubmed>long:3862195}})) 
   * olmesartan may uniquely increase urinary ACE2 level, which could offer additional renoprotective effects  (({{pubmed>long:24842388}}))    * olmesartan may uniquely increase urinary ACE2 level, which could offer additional renoprotective effects  (({{pubmed>long:24842388}})) 
Line 104: Line 104:
  
  
-=== Recent studies showed ===+=== Studies also showed ===
  
  
home/food/aim_health/aging.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.